Table 1.
Baseline characteristics for AGES-RS (1a) and MPP-RES (1b) subjects, by glucometabolic groups.
| Ia. | ||||||
|---|---|---|---|---|---|---|
| FG ≤5.0 | 5.1–5.5 | 5.6–6.0 | IFG | New-onset | Prevalent | |
| DM | DM | |||||
| Number | 82 | 218 | 144 | 82 | 23 | 59 |
| Age (years ±SD) | 77±6 | 75±6 | 75±6 | 76±6 | 76±5 | 76±6 |
| Sex (% men) | 78% | 68% | 50% | 60% | 48% | 46% |
| BMI (kg/m2) | 25.1±4.1 | 26.8±3.9 | 27.0±4.1 | 29.0±4.6 | 29.0±5.1 | 29.5±5.6 |
| Systolic BP (mmHg) | 143±23 | 142±21 | 142±18 | 142±20 | 148±16 | 144±21 |
| Diastolic BP (mmHg) | 74±9 | 74±9 | 75±9 | 74±9 | 80±9 | 73±8 |
| Total cholesterol* | 6.0±1.1 | 6.0±1.0 | 5.8±1.0 | 6.1±1.1 | 6.0±1.4 | 5.3±1.3 |
| HDL cholesterol* | 1.71±0.42 | 1.63±0.47 | 1.59±0.43 | 1.57±0.39 | 1.44±0.42 | 1.37±0.31 |
| Triglycerides* | 1.01±0.48 | 1.11±0.47 | 1.12±0.48 | 1.36±0.56 | 1.73±0.81 | 1.45±0.60 |
| Current smoker | 6% | 11% | 11% | 9% | 4% | 9% |
| Ib. | ||||||
|---|---|---|---|---|---|---|
| FG ≤5.0 | 5.1–5.5 | 5.6–6.0 | IFG | New-onset | Prevalent | |
| DM | DM | |||||
| Number | 134 | 224 | 213 | 436 | 152 | 360 |
| Age (years ±SD) | 69±5 | 67±6 | 66±6 | 66±6 | 67±6 | 68±6 |
| Sex (% men) | 41% | 62% | 66% | 78% | 78% | 72% |
| BMI (kg/m2) | 26.1±3.3 | 26.9±3.8 | 26.9±3.6 | 28.5±4.0 | 30.3±4.9 | 29.4±4.4 |
| Systolic BP (mmHg) | 143±18 | 142±20 | 146±16 | 150±20 | 156±23 | 148±19 |
| Diastolic BP (mmHg) | 83±10 | 83±10 | 85±10 | 87±10 | 89±10 | 83±10 |
| Total cholesterol* | 5.8±0.9 | 5.7±0.9 | 5.7±1.1 | 5.7±1.1 | 5.8±1.2 | 5.0±1.0 |
| HDL cholesterol* | 1.6±0.4 | 1.4±0.4 | 1.4±0.4 | 1.3±0.4 | 1.2±0.3 | 1.3±0.4 |
| Triglycerides* | 1.1±0.5 | 1.2±0.6 | 1.3±0.8 | 1.5±0.9 | 2.1±1.6 | 1.6±1.0 |
| Current smoker | 19% | 17% | 19% | 20% | 23% | 14% |
*
mmol/L.
BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; IFG, impaired fasting glucose; SD, standard deviation.